Coherus BioSciences Announces New Employment Inducement Grants
October 24 2023 - 7:41PM
Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq:
CHRS), today announced that effective October 20, 2023, the
compensation committee of the Company’s board of directors granted
options to purchase an aggregate of 64,500 shares of the common
stock of the Company to eight newly hired employees with a per
share exercise price of $3.54, the closing trading price on the
grant date.
The stock options were granted pursuant to the Coherus
BioSciences, Inc. 2016 Employment Commencement Incentive Plan,
which was approved by the Company’s board of directors in June 2016
under Rule 5635(c)(4) of the Nasdaq Global Select Market for equity
grants to induce new employees to enter into employment with the
Company.
Coherus BioSciences Contact Information:
IR ContactJodi SieversCoherus BioSciences,
Inc.IR@coherus.com
Coherus BioSciences (NASDAQ:CHRS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Coherus BioSciences (NASDAQ:CHRS)
Historical Stock Chart
From Jul 2023 to Jul 2024